Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Hematology|May 6, 2004
Farnesyltransferase inhibitors (FTIs) in myeloid malignanciesJ E Karp, J E Lancet
Hematology/Oncology Clinics of North America|February 19, 2000
Acute myelogenous leukemia and aging. Clinical interactionsJ E Lancet, C L Willman, J M Bennett
Current Opinion in Oncology|October 24, 2001
Current status of clinical trials of farnesyltransferase inhibitorsJ E Karp, S H Kaufmann, A A Adjei, et al.
Leukemia|September 13, 2003
Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesisJ L Liesveld, J E Lancet, K E Rosell, et al.
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Leukemia Research|July 31, 2012
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemiaE J Feldman, J E Kolitz, J M Trang, et al.
Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.
Leukemia|January 24, 2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research ConsortiumA M Zeidan, N Al Ali, J Barnard, et al.
Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.
Bone Marrow Transplantation|August 28, 1998
Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factorsJ E Lancet, A P Rapoport, R Brasacchio, et al.
Pageof 2